BEUDAMED
    17 results · 7ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters Classification: FDA Class 2 ×

    Implant, Endosseous, Root-Form

    FDA Pre-Market Approval
    FDA Class 2 ·ALVEOFORM TM BIOGRAFT

    Bone Grafting Material, Animal Source

    FDA Pre-Market Approval
    FDA Class 2 ·ALVEOFORM TM BIOGRAFT

    Bone Grafting Material, Animal Source

    FDA Pre-Market Approval
    FDA Class 2 ·ALVEOFORM TM BIOGRAFT

    Bone Grafting Material, Animal Source

    FDA Pre-Market Approval
    FDA Class 2 ·ALVEOFORM TM BIOGRAFT

    Bone Grafting Material, Animal Source

    FDA Pre-Market Approval
    FDA Class 2 ·ALVEOFORM TM BIOGRAFT

    Bone Grafting Material, Animal Source

    FDA Pre-Market Approval
    FDA Class 2 ·ALVEOFORM TM BIOGRAFT

    Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

    FDA Pre-Market Approval
    FDA Class 2 ·AXSYM CORE 2.0 AND AXSYM CORE 2.0 CONTROLS

    Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

    FDA Pre-Market Approval
    FDA Class 2 ·AXSYM CORE 2.0

    Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

    FDA Pre-Market Approval
    FDA Class 2 ·AXSYM CORE 2.0

    Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

    FDA Pre-Market Approval
    FDA Class 2 ·AXSYM CORE

    Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

    FDA Pre-Market Approval
    FDA Class 2 ·AXSYM CORE 2.0 (LN 8B88)

    Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

    FDA Pre-Market Approval
    FDA Class 2 ·AXSYM CORE 2.0 & AXSYM CORE 2.0 CONTROLS

    Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

    FDA Pre-Market Approval
    FDA Class 2 ·AXSYM CORE 2.0

    Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

    FDA Pre-Market Approval
    FDA Class 2 ·AXSYM CORE 2.0

    Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

    FDA Pre-Market Approval
    FDA Class 2 ·AXSYM CORE 2.0 (LN 8B88)

    Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

    FDA Pre-Market Approval
    FDA Class 2 ·AXSYM CORE 2.0

    Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)

    FDA Pre-Market Approval
    FDA Class 2 ·AXSYM CORE